Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2003 | 2 |
2005 | 2 |
2007 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing.
Cancer Chemother Pharmacol. 2005 Sep;56(3):248-54. doi: 10.1007/s00280-004-0988-6. Epub 2005 Apr 27.
Cancer Chemother Pharmacol. 2005.
PMID: 15856231
Pharmacokinetics of combined doxorubicin and paclitaxel in mice.
Gustafson DL, Merz AL, Long ME.
Gustafson DL, et al.
Cancer Lett. 2005 Apr 8;220(2):161-9. doi: 10.1016/j.canlet.2004.09.007.
Cancer Lett. 2005.
PMID: 15766591
Item in Clipboard
A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to man.
Bradshaw-Pierce EL, Eckhardt SG, Gustafson DL.
Bradshaw-Pierce EL, et al.
Clin Cancer Res. 2007 May 1;13(9):2768-76. doi: 10.1158/1078-0432.CCR-06-2362.
Clin Cancer Res. 2007.
PMID: 17473210
Item in Clipboard
Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens.
Gustafson DL, Long ME.
Gustafson DL, et al.
Chem Biol Interact. 2001 Oct 25;138(1):43-57. doi: 10.1016/s0009-2797(01)00257-5.
Chem Biol Interact. 2001.
PMID: 11640914
Item in Clipboard
Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
Gustafson DL, Siegel D, Rastatter JC, Merz AL, Parpal JC, Kepa JK, Ross D, Long ME.
Gustafson DL, et al.
J Pharmacol Exp Ther. 2003 Jun;305(3):1079-86. doi: 10.1124/jpet.103.050070. Epub 2003 Mar 20.
J Pharmacol Exp Ther. 2003.
PMID: 12649308
Item in Clipboard
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay.
Gustafson DL, Long ME, Zirrolli JA, Duncan MW, Holden SN, Pierson AS, Eckhardt SG.
Gustafson DL, et al.
Cancer Chemother Pharmacol. 2003 Aug;52(2):159-66. doi: 10.1007/s00280-003-0622-z. Epub 2003 May 21.
Cancer Chemother Pharmacol. 2003.
PMID: 12759775
Item in Clipboard
Cite
Cite